All terms in ONE
| Label | Id | Description |
|---|---|---|
| cell | CL_0000000 | [A material entity of anatomical origin (part of or deriving from an organism) that has as its parts a maximally connected cell compartment surrounded by a plasma membrane.] |
| lymphocyte | CL_0000542 | [A lymphocyte is a leukocyte commonly found in the blood and lymph that has the characteristics of a large nucleus, a neutral staining cytoplasm, and prominent heterochromatin.] |
| mononuclear cell | CL_0000842 | [A leukocyte with a single non-segmented nucleus in the mature form.] |
| biological activity assay measuring epitope specific oncostatin M production by T cells | OBI_0002058 | [A T cell epitope specific cytokine production assay that detects oncostatin M production by T cells.] |
| biological activity assay measuring epitope specific cytokine production by T cells | OBI_1110129 | [A T cell epitope dependent biological activity assay that detects cytokine production.] |
| antibody-dependent cellular cytotoxicity | GO_0001788 | [Cytolysis of target cells by natural killer cells, eosinophils, neutrophils, monocytes, or macrophages following engagement of antibodies bound to the target cells by Fc receptors on the effector cells.] |
| assay measuring a binding constant of a T cell epitope:MHC:TCR complex | OBI_0002059 | [A T cell epitope recognition assay that quantitavely characterizes the binding of a TCR with a ligand by determining a binding constant. ] |
| 3D structure determining assay of a MHC:ligand complex | OBI_0002050 | [A MHC:ligand binding assay that uses a 3D structure determination of bound complex assay.] |
| 3D structure determination of bound complex assay | OBI_0001145 | [A 3D structure determination assay in which a complex of 2 or more material enties is characterized which provides information on their binding configuration.] |
| in vivo assay measuring B cell epitope specific protection from infectious challenge based on pathogen burden | OBI_0002051 | [A B cell epitope in vivo intervention experiment that uses a epitope protection experiment based on pathogen burden.] |
| in vivo assay measuring B cell epitope specific protection from challenge | OBI_0001710 | [An efficacy of B cell epitope intervention experiment that uses a epitope protection experiment.] |
| epitope protection experiment | OBI_0001184 | [An efficacy of epitope intervention experiment that tests the efficacy of inducing an immune epitope response to prevent disease in a host. ] |
| in vivo assay measuring B cell epitope specific protection from tumor challenge | OBI_0002052 | [A B cell epitope in vivo intervention experiment that uses a epitope protection experiment based on tumor burden.] |
| cancer cell line | OBI_0001906 | [An immortal cell line derived from a transformed cell that was part of a malignant tumor.] |
| microarray assay measuring binding of a B cell epitope:antibody complex | OBI_0002053 | [A B cell epitope qualitative binding to antibody assay that uses a microarray.] |
| assay measuring qualitiative binding of a B cell epitope:antibody complex | OBI_0001703 | [A B cell epitope recognition assay that detects qualitative binding.] |
| NMR assay measuring the dissociation constant [KD] of a B cell epitope:antibody complex | OBI_0002054 | [A B cell epitope equilibrium dissociation constant (KD) determination assay that uses a nuclear magnetic resonance assay.] |
| assay measuring the dissociation constant [KD] of a B cell epitope:antibody complex | OBI_0001708 | [A B cell epitope binding constant determination assay that measures the dissociation constant KD.] |
| assay measuring T cell epitope specific biological activity | OBI_0002055 | [A T cell epitope recognition assay that detects biological activity.] |
| biological activity assay measuring epitope specific chemokine (C-C motif) ligand 17 production by T cells | OBI_0002056 | [A T cell epitope specific cytokine production assay that detects production of chemokine (C-C motif) ligand 17 production by T cells.] |